Anbio Biotechnology (NNNN) Common Equity (2023 - 2025)
Anbio Biotechnology (NNNN) posted quarterly Common Equity of $30.2 million for Q4 2025, up 75.41% year-over-year from $17.2 million in Q4 2024, and down 100.0% quarter-over-quarter from $27549.5 billion in Q2 2025.
Anbio Biotechnology (NNNN) Common Equity (2023 - 2025) Analysis & Trends
Anbio Biotechnology (NNNN) has reported Common Equity for 3 consecutive years, with $30.2 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Common Equity rose 75.41% year-over-year to $30.2 million; the TTM figure through Dec 2025 stood at $30.2 million (up 75.41% YoY), while the FY2025 annual figure was $30.2 million, up 75.41% from the prior year.
- Common Equity fell to $30.2 million in Q4 2025 per NNNN's latest filing, from $27549.5 billion in the prior quarter.
- Across five years, Common Equity topped out at $27549.5 billion in Q2 2025 and bottomed at $14.8 million in Q4 2023.
- Historically, Common Equity has averaged $6887.4 billion across 3 years, with a median of $23.7 million in 2024.
- Annual changes were most pronounced in 2024 — Common Equity climbed 16.01% — and 2025, when it surged 75.41%.
- Anbio Biotechnology's Common Equity stood at $14.8 million in 2023, then gained by 16.01% to $17.2 million in 2024, then soared by 75.41% to $30.2 million in 2025.
- Business Quant data shows NNNN's Common Equity at $30.2 million in Q4 2025, $27549.5 billion in Q2 2025, and $17.2 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 135.01 Bn | 129.79 Bn | 1.96 Bn | 18.30 Bn |
| 2 | Becton Dickinson | 52.53 Bn | 51.67 Bn | 2.32 Bn | 24.42 Bn |
| 3 | Alcon | 35.77 Bn | 34.41 Bn | 1.68 Bn | 21.60 Bn |
| 4 | Resmed | 33.97 Bn | 32.50 Bn | 861.22 Mn | 6.59 Bn |
| 5 | Medline | 29.06 Bn | 26.38 Bn | 2.22 Bn | 19.08 Bn |
| 6 | West Pharmaceutical Services | 25.01 Bn | 24.58 Bn | 329.20 Mn | 2.99 Bn |
| 7 | Solventum | 15.34 Bn | 14.94 Bn | 1.29 Bn | 4.80 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 8.24 Bn |
| 9 | Baxter International | 13.62 Bn | 11.47 Bn | 1.03 Bn | 6.21 Bn |
| 10 | Anbio Biotechnology | 314.00 Mn | 302.10 Mn | - | 30.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.16 Mn |
| Jun 30, 2025 | 27,549.47 Bn |
| Dec 31, 2024 | 17.19 Mn |
| Dec 31, 2023 | 14.82 Mn |